NFKB1 and chronic obstructive pulmonary disease: Interestingly, after ESW treatment, we here observed a decrement of the NF-κB-p65 proinflammatory transcription factor in COPD–primary bronchial fibroblasts and an increment of this protein in CS–primary bronchial fibroblasts and in 16HBE treated cells.